The Plan aims to provide patients with timely access to the latest genomic innovations and integrate genomics into routine healthcare to improve diagnosis and treatment, reduce diagnostic errors, and personalise therapeutic strategies.
Name in original language
France médecine génomique 2025
Initiative overview
The Ministry of Health officially launched in December 2016 a national call for projects, marking the start of funding for the first two genomic platforms dedicated to diagnostics and therapeutic monitoring, out of a total of 12 platforms expected within five years. These centers of excellence illustrate the ongoing support of public authorities for medical innovation, particularly for high-throughput human genome sequencing, which underpins genomic medicine, also referred to as “personalized” medicine.
Key focus areas include:
- Cancer: Enables more effective therapeutic adaptation, particularly through immunotherapy
- Rare diseases: Improves diagnosis for ~7,000 identified rare diseases, ending the “diagnostic wandering” patients often experience
- Common diseases: Addresses major metabolic disorders (e.g., diabetes, obesity), cardiovascular diseases, and neurodegenerative diseases (e.g., Alzheimer’s)
Name of responsible organisation (in English)
Ministry of Health and Access to Care
